Disease activity scores (DAS28, SLEDAI), gout criteria, and autoimmune indices.
Diagnoses rheumatoid arthritis (RA) in patients with undifferentiated inflammatory synovitis using joint involvement, serology, acute-phase reactants, and symptom duration
Provides formal diagnostic criteria for gout using a 3-step approach: entry criterion, sufficient criterion, and classification criteria requiring ≥7 points for positive diagnosis
Risk stratifies for gout vs non-gout arthritis and helps determine which patients benefit most from joint aspiration. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis.
Calculates age-adjusted ESR and CRP in adult rheumatoid arthritis patients to account for age-related increases in inflammatory markers
Classifies axial spondyloarthritis according to Assessment of Spondyloarthritis International Society (ASAS) criteria. This classification system allows for early diagnosis of axial SpA by incorporating both clinical and imaging features.
Classifies peripheral spondyloarthritis according to the Assessment of SpondyloArthritis International Society (ASAS) criteria
Stratifies severity of ankylosing spondylitis (AS) using clinical and laboratory data, specifically CRP. ASAS-endorsed disease activity score for monitoring AS treatment response.
Stratifies severity of ankylosing spondylitis (AS) using clinical and laboratory data, specifically ESR. The ASDAS-ESR is a composite index to assess disease activity in axial spondyloarthritis, combining patient-reported outcomes with laboratory measures to provide a comprehensive evaluation of disease activity.
Bath Ankylosing Spondylitis Disease Activity Index.
Bath AS Functional Index: 10-item functional assessment.
International Study Group criteria for Behcet syndrome.
Assesses 10-year absolute fracture risk based on age, sex, femoral neck T-score, and clinical risk factors. Stratifies patients into low (<10%), moderate (10-20%), or high (>20%) risk categories for major osteoporotic fractures.
Provides standardized classification criteria for identifying psoriatic arthritis (PsA) in patients with inflammatory arthritis. Requires presence of inflammatory articular disease plus ≥3 points from additional criteria.
Determines severity of rheumatoid arthritis using only clinical data, without laboratory tests
Psoriatic arthritis disease activity score.
Describes severity of rheumatoid arthritis using clinical and laboratory data, specifically CRP
Describes severity of rheumatoid arthritis using clinical and laboratory data, specifically ESR
Sjogren's syndrome systemic disease activity (12 weighted domains).
Classifies polymyalgia rheumatica by expert consensus recommendations using clinical and optionally ultrasonographic criteria
Predicts 5-year hip fracture risk in postmenopausal women using clinical risk factors with or without bone mineral density measurements.
Calculates maximum daily hydroxychloroquine dose to reduce retinopathy risk. Uses actual body weight to determine safe dosing limits based on 2016 American Academy of Ophthalmology guidelines recommending ≤5 mg/kg/day to minimize retinal toxicity.
Differentiates between active and inactive disease in Takayasu arteritis (TA). The ITAS2010 is a validated clinical activity measure specifically developed for Takayasu arteritis, incorporating 44 clinical items with emphasis on cardiovascular manifestations (33 out of 44 items). The score was developed from the Disease Extent Index (DEI.Tak) and validated in over 300 TA patients with excellent inter-observer reliability (IRR 0.97). It assesses new or worsening symptoms within the past 3 months across multiple organ systems including systemic, abdominal, genitourinary, renal, neurological, and cardiovascular domains. Seven key cardiovascular items carry higher weight (2 points each) reflecting their clinical significance in disease activity assessment.
2015 AHA Jones criteria for diagnosing acute rheumatic fever, with streptococcal evidence requirement.
Diagnoses rheumatoid arthritis in patients with recent-onset undifferentiated arthritis by predicting the likelihood of progression from undifferentiated arthritis to rheumatoid arthritis within one year
Identifies women at risk for osteoporosis and recommends bone densitometry. Uses age, weight, and current estrogen use to stratify risk in postmenopausal women.
Predicts risk of osteoporosis based on age and body weight. Simple screening tool to identify individuals who may benefit from further bone density testing with DXA scanning.
3-item RA activity index (function, pain, patient global), each 0-10; total 0-30.
SDAI = TJC28 + SJC28 + PGA + EGA + CRP; <=3.3 remission, <=11 low, <=26 moderate, >26 high.
Stratifies severity of systemic lupus erythematosus (SLE) based on 24 clinical and laboratory parameters, allowing documentation of persistent disease activity.
Clinical Decision Support (CDS) Notice & Legal Disclaimer
All calculations and clinical scoring tools in this directory are intended strictly for educational and decision-support use by licensed medical practitioners. They do not constitute autonomous medical advice or direct treatment orders. See the full DexaMed Medical Disclaimer.